Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-12 · accession 0001209191-22-024130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-12 | 2022-04-12 | CCCC | Hirsch Andrew | Pres, CEO, Dir | P - Purchase | $8.40 | +10.0K | 10.0K | New | +$84.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-12 | P | A | 10,000 | $8.40 | 10,000 | D | — | — |